Caris Life Sciences, Inc.

CAI · Nasdaq · SIC 8071: Services-Medical Laboratories
13
SEC Filings

Business Summary

Part I Overview We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. We found...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCAIdiscussed_in_filing Artificial Intelligence
topic_mentionCAIdiscussed_in_filing Trusted Computing
topic_mentionCAIdiscussed_in_filing Blockchain & Crypto
topic_mentionCAIdiscussed_in_filing Regulation
topic_mentionCAIdiscussed_in_filing Healthcare & Bio
topic_mentionCAIdiscussed_in_filing Platform & Ecosystem
topic_mentionCAIdiscussed_in_filing Artificial Intelligence
topic_mentionCAIdiscussed_in_filing Trusted Computing
topic_mentionCAIdiscussed_in_filing Blockchain & Crypto
topic_mentionCAIdiscussed_in_filing Regulation
topic_mentionCAIdiscussed_in_filing Healthcare & Bio
topic_mentionCAIdiscussed_in_filing Platform & Ecosystem
topic_mentionCAIdiscussed_in_filing Artificial Intelligence
topic_mentionCAIdiscussed_in_filing Trusted Computing
topic_mentionCAIdiscussed_in_filing Blockchain & Crypto
topic_mentionCAIdiscussed_in_filing Regulation
topic_mentionCAIdiscussed_in_filing Healthcare & Bio
topic_mentionCAIdiscussed_in_filing Platform & Ecosystem
topic_mentionCAIdiscussed_in_filing Artificial Intelligence
topic_mentionCAIdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310002019410-26-000016EDGAR114K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300002019410-25-000028EDGAR93K words
2025-08-122025-06-300002019410-25-000012EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020002019410-26-000019EDGAR1K words
2026-02-260002019410-26-000011EDGAR
2026-01-120002019410-26-000005EDGAR
2025-11-050002019410-25-000026EDGAR
2025-10-300002019410-25-000020EDGAR
2025-08-120002019410-25-000011EDGAR
2025-06-200001104659-25-061148EDGAR

13 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AMS — AMERICAN SHARED HOSPITAL SERVICES ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Company Identity

CIK0002019410
TickerCAI
ExchangeNasdaq
SIC8071: Services-Medical Laboratories
IncorporatedTX

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4b8d44fb473ee1f08f0e4e2ada026660e2f0e5c54f8280ed875634c8e2e9de95
parent: 88781c2116e8e77fc509b400b40fdeb0ad6964b48ff38b04a11d94996fa8b77b
content hash: 89d394d14f29d5464e89a7242e994fc6695aecedb0885eb7ece4ffc7137937a0
signed: 2026-04-13T04:44:11.038Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf